[Anantha Shekhar, MD, PhD]
“This was an incredibly difficult decision for me and this transition is truly bittersweet,” said Dr. Shekhar. “I’ve been at Indiana University School of Medicine for more than three decades. I earned my doctorate degree and performed my residency here, directed the psychiatry department, founded the Indiana Clinical and Translational Sciences Institute, and led all of Research. It’s been a place I’ve spent more than half of my life, so a piece of my heart and hopefully my legacy, will always be in Indiana.”
The Indiana CTSI provides pilot funding, research services and collaborations across the three preeminent Indiana research institutes of Indiana University, Purdue University and the University of Notre Dame. Indiana CTSI is nationally recognized for its work as a statewide innovation platform for Indiana and has been continuously funded by the National Institutes of Health since its inception in 2008.
Currently Mark Geraci, MD, Chair of the Department of Medicine at IU School of Medicine, Sarah Wiehe, MD, MPH, and professor of pediatrics at IU School of Medicine, and George Wodicka, Professor of the Weldon School of Biomedical Engineering at Purdue University, serve as co-principal investigators of the Indiana CTSI and will remain in their leadership roles. Carmel Egan, PhD, will also continue to serve as Chief Operating Officer of Indiana CTSI.
Dr. Shekhar will continue his leadership of the Indiana CTSI through May 15, 2020. The new leadership structure for the Indiana CTSI will be finalized prior to his departure.
